CRYO-CELL International, Inc. (OTCMKTS:CCEL)’s share price crossed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $7.55 and traded as low as $7.24. CRYO-CELL International shares last traded at $7.60, with a volume of 1,510 shares.
The business has a fifty day simple moving average of $7.67 and a two-hundred day simple moving average of $7.56. The company has a market cap of $58.85 million, a PE ratio of 28.80 and a beta of -0.19.
CRYO-CELL International (OTCMKTS:CCEL) last posted its earnings results on Monday, July 15th. The company reported $0.01 earnings per share for the quarter. The company had revenue of $8.13 million during the quarter. CRYO-CELL International had a negative return on equity of 20.90% and a net margin of 4.57%.
CRYO-CELL International Company Profile (OTCMKTS:CCEL)
Cryo-Cell International, Inc engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, kidney, ALS, wound healing, and auto-immune diseases.
Recommended Story: How is a price target determined?
Receive News & Ratings for CRYO-CELL International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CRYO-CELL International and related companies with MarketBeat.com's FREE daily email newsletter.